| Juandena Jennings, | |
|
4660 Martin Luther King Jr Ave Sw, Washington, DC 20032-4933 | |
| (202) 892-9846 | |
| Not Available |
| Full Name | Juandena Jennings |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Family |
| Location | 4660 Martin Luther King Jr Ave Sw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154935591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TF0000X | Psychologist - Family | (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Juandena Jennings, 5316 E St Se, Washington, DC 20019-6050 Ph: (202) 805-6029 | Juandena Jennings, 4660 Martin Luther King Jr Ave Sw, Washington, DC 20032-4933 Ph: (202) 892-9846 |
News Archive
Life Technologies Corporation and the University of California at San Diego Moores Cancer Center today announced a partnership to use SOLiD 4 genomic analysis technology in a research program to study chronic lymphocytic leukemia, a cancer of the white blood cells. The CLL research is made possible by funding from the National Institutes of Health and will enable scientists to survey the whole transcriptomes of 96 CLL tumor samples for potential biomarkers.
Although the threat of another tornado is gone for now, other potential dangers lurk in the storm's aftermath, said several University of Alabama at Birmingham experts. They recently offered tips on how to stay safe and heal emotionally in the days after the devastating April 27 storm.
Repligen Corporation today reported results for the third quarter of fiscal year 2011, ended December 31, 2010. Total revenue for the quarter was $7,068,000 compared to total revenue of $5,617,000 for the third quarter of fiscal year 2010 ended December 31, 2009, an increase of $1,451,000 or 26%.
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that it will present final results from the Phase 1 study of AB928, its dual adenosine receptor antagonist, in healthy volunteers during a poster display session at the European Society of Medical Oncology 2018 Congress, being held October 19-23, 2018, in Munich, Germany.
› Verified 8 days ago
Dr. Leila Bremer, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1330 New Hampshire Ave Nw, Suite 106, Washington, DC 20036 Phone: 202-887-0404 | |
Dr. Chester Wayne Bullock Jr., PSYD, MED Psychologist Medicare: Not Enrolled in Medicare Practice Location: 910 17th St Nw Ste 419, Washington, DC 20006 Phone: 202-505-2795 | |
Dr. Megan Laabs, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6900 Georgia Ave Nw, Washington, DC 20307 Phone: 202-782-8671 | |
Dana Footer, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Dr. Jennifer Lee Bakalar, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2000 P St Nw Ste 408, Washington, DC 20036 Phone: 202-932-0893 | |
Dr. Karin Leah Arndt, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4601 Connecticut Ave Nw, Suite 20, Washington, DC 20008 Phone: 716-239-0723 | |
Renee Michelle Neely-walters, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5800 8th St Nw, Washington, DC 20011 Phone: 202-541-6608 |